Celularity (CELUW) Depreciation and Depletion (2020 - 2025)
Celularity (CELUW) reported Depreciation and Depletion of $1.4 million for Q4 2025, down 4.87% year-over-year from $1.5 million in Q4 2024, and down 1.45% quarter-over-quarter from $1.4 million in Q3 2025.
Celularity (CELUW) Depreciation and Depletion (2020 - 2025) Analysis & Trends
Celularity (CELUW) has 5 years of Depreciation and Depletion data on file, last reported at $1.4 million in Q4 2025.
- Depreciation and Depletion for Q4 2025 came in at $1.4 million, down 4.87% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.8 million (down 5.93% YoY), and the FY2025 annual result was $5.8 million, down 5.93% from the prior year.
- Depreciation and Depletion retreated to $1.4 million in Q4 2025 per CELUW's latest filing, from $1.4 million in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $2.1 million in Q4 2021 and troughed at $1.4 million in Q1 2021.
- A 4-year average of $1.6 million and a median of $1.5 million in 2024 frame the typical range for Depreciation and Depletion.
- The sharpest annual moves came in 2021 and 2025: Depreciation and Depletion surged 60.22% in 2021, then decreased 8.94% in 2025.
- A 4-year view of Depreciation and Depletion shows it stood at $2.1 million in 2021, then fell by 15.14% to $1.7 million in 2022, then dropped by 13.94% to $1.5 million in 2024, then retreated by 4.87% to $1.4 million in 2025.
- Business Quant data shows CELUW's Depreciation and Depletion at $1.4 million in Q4 2025, $1.4 million in Q3 2025, and $1.5 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Celularity | - | - | -3.27 Mn | 1.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.43 Mn |
| Dec 31, 2025 | 1.43 Mn |
| Sep 30, 2025 | 1.45 Mn |
| Sep 30, 2025 | 1.45 Mn |
| Jun 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 1.46 Mn |
| Mar 31, 2025 | 1.47 Mn |
| Mar 31, 2025 | 1.47 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | 1.52 Mn |
| Sep 30, 2024 | 1.52 Mn |
| Jun 30, 2024 | 1.54 Mn |
| Jun 30, 2024 | 1.54 Mn |
| Mar 31, 2024 | 1.61 Mn |
| Mar 31, 2024 | 1.61 Mn |
| Mar 31, 2022 | 1.74 Mn |
| Mar 31, 2022 | 1.74 Mn |
| Dec 31, 2021 | 2.05 Mn |
| Dec 31, 2021 | 2.05 Mn |